Serum elimination half-life of tamoxifen and its metabolites in patients with advanced breast cancer
- PMID: 1458563
- DOI: 10.1007/BF00695998
Serum elimination half-life of tamoxifen and its metabolites in patients with advanced breast cancer
Abstract
In breast cancer patients discontinuing chronic tamoxifen therapy, the serum elimination of metabolites X, Y and E paralleled that of tamoxifen, whereas that of metabolite Z did not. The serum elimination of tamoxifen and metabolites X and B was increased by amino-glutethimide treatment, whereas that of metabolites Z, Y, and E was not.
References
MeSH terms
Substances
LinkOut - more resources
Medical